Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Dement Geriatr Cogn Disord. 2014 Oct 3;39(0):12–24. doi: 10.1159/000365587

Longitudinal Declines in Instrumental Activities of Daily Living in Stable and Progressive Mild Cognitive Impairment

Julia J Hsiao 1,2, Po H Lu 1, Joshua D Grill 1, Edmond Teng 1,2
PMCID: PMC4312538  NIHMSID: NIHMS624685  PMID: 25300404

Abstract

Background

Previous cross-sectional studies suggest that assessments of instrumental activities of daily living (IADLs) may be useful for operationalizing the differences in functional deficits seen in mild cognitive impairment (MCI) and dementia. However, their utility for longitudinal changes in IADLs in the transition between MCI and dementia remains unclear.

Methods

We analyzed longitudinal IADL data with the Functional Activities Questionnaire (FAQ) in stable (MCI-S; n=1318) or progressive (MCI-P; n=1108) MCI.

Results

Larger FAQ increases were seen in the MCI-P group across a 14.5-month interval, but overlapping distributions in the two groups yielded poorer discriminatory power than prior cross-sectional reports.

Conclusion

Our findings emphasize the difficulties in operationalizing the criterion of “essentially intact” IADLs in MCI, which may complicate the interpretation of disease progression in MCI treatment trials.

Keywords: MCI, dementia, diagnosis, activities of daily living, functional abilities, assessment measures

INTRODUCTION

The transitional stage between normal cognitive aging and dementia has been termed mild cognitive impairment (MCI) [1]. The core diagnostic criteria for MCI include: 1) subjective cognitive complaints, 2) objective cognitive impairment, and 3) essentially intact activities of daily living (ADLs) [1]. The criterion specifying essentially intact ADLs is often the primary feature that distinguishes MCI from dementia, since subjective and objective cognitive impairment can be present in both diagnoses [2,3], and declines in instrumental ADLs (IADLs) are more strongly associated with progression from MCI to dementia than declines in cognitive function [4].

In the most recent diagnostic criteria for dementia due to Alzheimer's disease (AD), the decision regarding whether ADLs are “essentially intact” is considered to be “inherently a clinical judgment made by a skilled clinician on the basis of the individual circumstances of the patient” [2]. However, previous studies using standardized ADL measures have consistently reported poorer performance in individuals diagnosed with MCI relative to cognitively normal controls [5-14]. Since there are no explicit guidelines regarding the extent of functional impairment allowable within the definition of “essentially intact” ADLs required for a diagnosis of MCI [15], the use of subjective evaluations to make this determination may result in significant inter-rater variability in both clinical and research settings [16].

An alternative approach to distinguishing ADL performance between MCI and dementia has been the use of standardized ADL questionnaires. Several studies have examined cross-sectional data to empirically determine the most effective cut-points on different assessments, including the Functional Activities Questionnaire (FAQ), Bayer Activities of Daily Living Scale, and modified Disability Assessment for Dementia scale, for separating participants diagnosed with MCI from those diagnosed with mild dementia, yielding sensitivities ranging from 80% to 83% and specificities ranging from 72% to 87% [17-19]. However, such cross-sectional comparisons may overestimate the utility of these assessment tools for making the more difficult diagnostic distinctions near the transition between MCI and dementia, since they include a range of participants at different stages of disease progression. Furthermore, cross-sectional studies are also unable to delineate the magnitude of functional decline across the interval that marks a change in diagnosis between MCI and dementia.

We sought to address these issues by examining longitudinal changes in FAQ scores among individuals meeting criteria for MCI whose data are included in the Unified Data Set (UDS). The UDS is a large nationwide database that is maintained by the National Alzheimer's Coordinating Center (NACC) and compiled from participants evaluated through the Alzheimer's Disease Centers (ADCs) supported by the National Institute on Aging (NIA) [20]. We analyzed longitudinal FAQ data collected at approximately annual standardized assessments and compared interval changes in FAQ indices between individuals with stable MCI and those who progressed to dementia. These analyses allowed us to examine the validity of global FAQ cut-points for distinguishing MCI and mild dementia that were derived in a prior cross-sectional study [17] and to quantify the changes in FAQ indices associated with expert ADC clinicians’ judgment regarding the transition between the “essentially intact” ADLs that characterize MCI and the “impaired” ADLs that define dementia.

METHODS

Research Participants

The NACC UDS contains longitudinal data from 34 ADCs with current or prior funding from the NIA, and includes participants with normal cognition, MCI, and dementia [20]. From the UDS, we identified 3183 participants who were ≥ 50 years of age, diagnosed with MCI per modified Petersen criteria [1] at their initial visit, returned for at least one follow-up visit, received serial assessments with the Functional Activities Questionnaire (FAQ), and whose data had been entered into the UDS by March 1, 2012. We eliminated 757 participants who reverted to normal cognition from further analyses. The remaining participants were divided into two groups based on whether their MCI diagnosis remained stable (MCI-S; n=1318) or progressed to dementia due to AD [21] or other etiologies (MCI-P; n=1108). Race/ethnicity data was dichotomized into two categories: non-Hispanic Whites and other races/ethnicities. Diagnoses are independently determined at each ADC through clinician judgment and/or neuropsychological testing (including additional measures beyond those incorporated in the UDS) [20]. Participants meeting criteria for MCI exhibited deficits in attention, memory, language, visuospatial, and/or executive functioning. MCI was subtyped as amnestic or nonamnestic based on the presence or absence of significant memory impairment; both groups included participants with deficits in single or multiple cognitive domains.

Functional and Cognitive Assessments

IADL performance was assessed using the FAQ [22]. The FAQ solicits informant ratings of participants’ performance on 10 separate categories of IADLs: 1) writing checks, paying bills, keeping financial records; 2) assembling tax or business records; 3) shopping alone; 4) playing a game of skill; 5) making coffee or tea; 6) preparing a balanced meal; 7) keeping track of current events; 8) attending to and understanding a television program, book, or magazine; 9) remembering appointments, family occasions, medications; and 10) traveling out of the neighborhood. Each category is rated from 0 to 3 (0: normal; 1: has difficulty, but does by self; 2: requires assistance; 3: dependent), with higher scores indicative of poorer performance. Activities were not rated if the participant never performed them prior to developing cognitive difficulties or if the informant had insufficient information to provide a valid response. Global FAQ indices were calculated two ways to accommodate missing data: (A) total FAQ scores, which only include data from participants with valid responses for all items, and (B) average FAQ item scores, which include data from all participants [5,17]. Prior work indicates that individual ADCs do not incorporate specific cut-off points on global FAQ indices to distinguish between MCI and dementia [17]. Cognitive performance was measured using the Mini-Mental Status Examination (MMSE) [23].

Statistical Analyses

Statistical analyses were performed using SPSS 22 for Mac (IBM, Armonk NY). Given the variability in the overall length of follow-up for MCI participants in the UDS, we focused on the most recent longitudinal intervals included in this dataset. For the MCI-S group, we calculated the relative changes in FAQ indices between the last recorded UDS visit (visit F) and the visit that immediately preceded it (visit F-1). For the MCI-P group, we calculated the relative changes in FAQ indices between the first visit at which these participants received a diagnosis of dementia (visit F), and the two visits immediately preceding it, during which they still met diagnostic criteria for MCI (visits F-1 and F-2). Cross-sectional data were compared between groups using unpaired t-tests for continuous variables and chi-squared tests for categorical variables. FAQ indices were compared across the MCI-S and MCI-P groups using analysis of covariance (ANCOVA) and adjusted for demographic differences. Within-subject comparisons of global FAQ indices across visits F-2, F-1, and F in the MCI-P group were performed using paired t-tests. Binomial logistic regression was used to identify the changes in specific FAQ items that were most closely associated with diagnostic progression from MCI to dementia. Receiver operating characteristic (ROC) curves and sensitivity index scores (d’) were used to identify the discriminative power of and optimal cut-points for global FAQ indices associated with the diagnostic transition between MCI and dementia.

RESULTS

Demographics

Demographic and MMSE data for the MCI-S and MCI-P groups are shown in Table 1. MCI-P subjects were significantly older at visits F and F-1 (p's<0.001), more likely to be non-Hispanic Whites (p<0.001), more likely to be diagnosed with amnestic MCI at visit F-1 (p<0.001), and had lower MMSE scores (p<0.001) than MCI-S subjects. There were no differences between groups in the time interval between visits F and F-1, gender, or years of formal education. Subsequent analyses were adjusted for race as well as age, MCI subtype, and MMSE scores at visit F-1. In the MCI-P group, 86.6% of participants progressed to a diagnosis of possible or probable AD by visit F; the remainder were diagnosed with other dementing etiologies.

Table 1.

Demographic and cognitive data for MCI participants who remained diagnostically stable (MCI-S) or progressed to dementia (MCI-P).

MCI-S MCI-P t(2424)/χ2(2426)
N 1318 1108
Age: visit F-1 75.4 (8.7) 77.0 (8.7) −4.64*
Age: visit F 76.6 (8.7) 78.2 (8.7) −4.71*
Months between visits F-1 and F 14.4 (5.0) 14.7 (5.9) −1.33
Months between initial visit and visit F 27.6 (15.5) 23.8 (13.0) 6.40*
Years of Education 15.1 (3.1) 15.2 (3.1) 0.89
% Male 51.3% 51.6% 0.03
% Non-Hispanic White 78.3% 85.7% 22.28*
% Amnestic MCI at visit F-1 81.6% 89.6% 30.56*
MMSE at visit F-1 27.3 (2.3) 25.8 (2.7) 14.49*

Parentheses denote standard deviation (SD).

df=2418 due to missing data for 8 participants

df=2344 due to missing data for 80 participants.

Longitudinal changes in functional indices in the MCI-S and MCI-P groups between visits F-1 and F

Complete FAQ data was obtained from a greater proportion of the MCI-S group than of the MCI-P group at visits F-1 [MCI-S: 63.6%; MCI-P: 57.4%; χ2(2426)=9.64; p=0.002] and F [MCI-S: 64.0%; MCI-P: 58.5%; χ2(2426)=7.84; p=0.002]. The average number of FAQ items with valid responses was also significantly higher in the MCI-S group at visit F-1 [MCI-S: mean 9.36, SD 1.17; MCI-P: mean 9.22, SD 1.24; t(2424)=2.82; p=0.005] and marginally higher at visit F [MCI-S: mean 9.31, SD 1.38; MCI-P: mean 9.22, SD 1.25; t(2424)=2.82; p=0.094]. Nevertheless, over 90% of participants in each group had ≥8 FAQ items with valid responses at each visit.

Figure 1A illustrates total FAQ scores at visits F-1 and F. These data include only participants in the MCI-S (n=699) and MCI-P (n=502) groups with valid responses for each FAQ item at both visits. Repeated-measures ANCOVA indicated that across visits, significantly higher total FAQ scores were seen in the MCI-P group [F(1,1144)=102.50, p<0.001], in non-Hispanic Whites [F(1,1144)=5.70, p=0.017], and with greater age [F(1,1144)=10.16, p=0.001] and lower MMSE scores [F(1,1144)=21.15, p<0.001]. There was also a significant group x visit interaction [F(1,1144)=76.41, p<0.001], indicating that greater longitudinal increases in total FAQ scores were seen in the MCI-P group (mean=6.55, SD=7.07) relative to the MCI-S group (mean=1.01, SD=3.61). Significantly greater longitudinal increases in total FAQ scores were also seen among older participants [F(1,1144)=10.80, p=0.001] and non-Hispanic whites [F(1,1144)=5.70, p=0.017].

Figure 1.

Figure 1

Total FAQ scores (A) and average FAQ item scores (B) across visits F-1 and F in the MCI-S and MCI-P groups. Error bars indicate standard error of the mean (SEM). *p<0.05 versus MCI-S.

Figure 1B illustrates average FAQ item scores at visits F-1 and F, and includes data for all participants in the MCI-S and MCI-P groups. Similar to the results described above, repeated-measures ANCOVA across visits demonstrated significantly higher average FAQ item scores in the MCI-P group [F(1,2324)=132.21, p<0.001], in non-Hispanic Whites [F(1,2324)=10.02, p=0.002], and with greater age [F(1,2324)=8.63, p=0.003] and lower MMSE scores [F(1,2324)=47.07, p<0.001]. There were again significant group x visit [F(1,2404)=164.79, p<0.001] and age x visit [F(1,2404)=17.27, p<0.001] interactions, as larger increases in average FAQ item scores were seen in the MCI-P group (mean=0.63, SD=0.68) than in the MCI-S group (mean=0.10, SD=0.38), and in older individuals.

We further investigated whether the greater longitudinal changes in global FAQ indices in the MCI-P group were preferentially driven by changes in specific individual FAQ items. However, as shown in Figure 2, significantly larger increases in the MCI-P group relative to the MCI-S group were seen in all 10 FAQ items (critical p=0.005 after Bonferroni correction). Logistic regression analyses controlling for race, age, MCI subtype, and MMSE scores at visit F-1 indicated that greater increases in difficulties with bills, shopping, games, meal preparation, remembering dates, and traveling outside the neighborhood were each independently associated with progression to dementia (Table 2).

Figure 2.

Figure 2

Changes in individual FAQ items in the MCI-S and MCI-P groups between visits F-1 and F. Error bars indicate SEM. *p<0.005 versus MCI-S.

Table 2.

Logistic regression analysis of demographic and functional variables associated with a diagnosis of dementia at visit F.

B SE Wald χ2 OR (95% CI) P
Age 0.01 0.01 0.87 1.01 (0.99-1.02) 0.352
Non-Hispanic White 0.62 0.19 10.34 1.86 (1.28-2.72) 0.001
MCI subtype at F-1 0.37 0.22 2.78 1.44 (0.94-2.22) 0.096
MMSE at F-1 −0.23 0.03 51.75 0.80 (0.75-0.85) <0.001
Change in FAQ: bills 0.32 0.12 6.88 1.37 (1.08-1.74) 0.009
Change in FAQ: taxes 0.05 0.11 0.21 1.05 (0.85-1.31) 0.650
Change in FAQ: shopping 0.31 0.12 6.50 1.36 (1.08-1.72) 0.011
Change in FAQ: games 0.27 0.12 5.16 1.31 (1.04-1.66) 0.023
Change in FAQ: stove −0.26 0.13 4.09 0.77 (0.60-0.99) 0.043
Change in FAQ: meal preparation 0.45 0.12 14.64 1.58 (1.25-1.99) <0.001
Change in FAQ: current events 0.22 0.11 3.62 1.24 (0.99-1.55) 0.057
Change in FAQ: attention 0.11 0.13 0.78 1.12 (0.87-1.44) 0.377
Change in FAQ: remembering dates 0.25 0.11 5.25 1.28 (1.04-1.59) 0.022
Change in FAQ: traveling 0.23 0.10 6.01 1.26 (1.05-1.52) 0.014

Nagelkerke R2=0.374; SE: standard error; OR: odds ratio; CI: confidence interval

Longitudinal changes in functional indices in the MCI-P group between visits F-2 and F-1 and visits F-1 and F

The multiple demographic differences between the MCI-S and MCI-P groups (Table 1) raised the possibility that the MCI-S group may have included more individuals at earlier stages of disease progression and/or less likely to have underlying neurodegenerative etiologies than the MCI-P group. As such, comparisons of longitudinal changes in functional indices between the MCI-S and MCI-P groups may overstate the magnitude of changes in MCI that progresses to dementia relative to stable MCI, even after adjustmenting for demographic factors. Therefore, we performed additional analyses in a subset of the MCI-P group that had ≥ 3 study visits in the NACC UDS (n=490). For these participants, we compared longitudinal change scores across visits F-2 and F-1, during which their MCI diagnoses remained stable, with longitudinal change scores across visits F-1 and F, during which their diagnoses progressed from MCI to dementia. These within-subject analyses incorporated smaller sample sizes, but allowed for more direct investigations of the diagnostic transition from MCI to dementia without confounding demographic differences.

Demographic data for the subsets of MCI-P participants with ≥ 3 visits and only 2 visits are shown in Table 3. Relative to MCI-P participants with only 2 visits, those with ≥ 3 visits were older at visits F-1 (p=0.015) and F (p=0.026), had a higher proportion of non-Hispanic Whites (p=0.026), and were marginally more likely to have amnestic MCI at visit F-1 (p=0.051), but had similar years of education (p=0.74) and gender distribution (p=0.33). Global FAQ indices and MMSE scores for this subgroup are shown in Figure 3. Complete FAQ data was available for 62.4% of participants at visit F-2, 55.9% of participants at visit F-1, and 60.6% of participants at visit F. Significantly larger changes were seen across the F-1 to F interval relative to the F-2 to F-1 interval for total FAQ [F-1 to F: mean 6.36, SD 7.18; F-2 to F-1: mean 2.07, SD 5.02; t(180)=-5.84, p<0.001], average FAQ item [F-1 to F: mean 0.60, SD 0.66); F-2 to F-1: mean 0.21, SD 0.48; t(480)=-9.44, p<0.001], and MMSE [F-1 to F: mean -2.11, SD 3.19; F-2 to F-1: mean -0.85, SD 2.42; t(462)=-6.21, p<0.001] scores. The changes in each of these indices in the MCI-P group between visits F-2 and F-1 were significantly larger than those seen in the MCI-S group between visits F-1 and F [total FAQ: t(917)=3.98, p<0.001; average FAQ item: t(1789)=5.40, p<0.001; MMSE: t(1734)=3.42, p<0.001].

Table 3.

Demographic data for participants in the MCI-P group with either 2 or ≥ 3 visits.

2 visits ≥ 3 visits t(1106)/χ2(1108)
N 618 490 --
Age: visit F-2 n/a 76.6 (8.5) --
Age: visit F-1 76.5 (8.8) 77.7 (8.5) −2.22*
Age: visit F 77.7 (8.9) 78.9 (8.5) −2.43*
Years of Education 15.2 (3.2) 15.3 (3.0) −0.33
% Male 50.3% 53.3% 0.95
% Non-Hispanic White 83.6% 88.4% 4.96*
% Amnestic MCI 88.0% 91.6% 3.82

Parentheses denote SD

*

p<0.05

df=1101 due to missing data for 5 participants.

Figure 3.

Figure 3

Total FAQ scores (A), average FAQ item scores (B), and MMSE scores (C) in the MCI-P group across visits F-2, F-1, and F. Error bars indicate SEM. *p<0.05 versus visit F-2; †p<0.05 versus visit F-1.

Change scores for individual FAQ items in the MCI-P group across the F-2 to F-1 and F-1 to F intervals are shown in Figure 4. After Bonferroni correction (critical p = 0.005), paired t-tests demonstrated significantly greater increases across the F-1 to F interval relative to the F-2 to F-1 interval for all items except for assembling tax or business records [t(346)=-2.73, p=0.007)] and attending to and understanding a television program, book, or magazine [t(474)=−2.74, p=0.006)].

Figure 4.

Figure 4

Changes in individual FAQ items in the MCI-P group between visits F-2 and F-1 and between visits F-1 and F. Error bars indicate SEM. *p<0.005 versus F-2 to F-1 interval.

Diagnostic cut-points using global FAQ indices

Previous analyses of cross-sectional FAQ data from the NACC UDS indicated that the optimal cut-points for distinguishing MCI from very mild AD were < 6 for the total FAQ score (80.3% sensitivity, 87.0% specificity, and 84.7% classification accuracy) and < 0.437 for the average FAQ item score (81.8% sensitivity, 77.4% specificity, and 79.1% classification accuracy) [17]. However, when we applied these cut-points to the MCI-S and MCI-P groups at visit F, their overall predictive power decreased (total FAQ score: 83.6% sensitivity, 71.3% specificity, and 76.7% classification accuracy; average FAQ item score: 85.4% sensitivity, 61.9% specificity, and 72.6% classification accuracy) due to poorer specificity. Furthermore, when these cut-points were used to longitudinally classify the MCI-P group at visits F-1 (MCI) versus F (dementia), even lower specificities and classification accuracies were seen (total FAQ score: 48.8% specificity, and 66.2% classification accuracy; average FAQ item score: 43.2% specificity, and 64.3% classification accuracy).

ROC analyses of total FAQ scores across the MCI-S and MCI-P groups at visit F produced an area under the curve (AUC) of 0.851 [95% confidence interval (CI): 0.832-0.871, p<0.001] and d’ of 1.43. The optimal cut-point in this cohort was between 8 and 9, which yielded 74.8% sensitivity, 82.1% specificity, and 79.0% classification accuracy. When this cut-point was used to distinguish total FAQ scores in the MCI-P group at visits F-1 and F, specificity dropped to 64.1% and classification accuracy fell to 69.4%. ROC analyses of average FAQ item scores across the MCI-S and MCI-P groups at visit F produced an AUC of 0.826 (95% CI: 0.809-0.842, p<0.001] and d’ of 1.28. The optimal cut-point was between 0.731 and 0.732, which yielded 73.9% sensitivity, 76.6% specificity, and 75.4% classification accuracy. When this cut-point was used to distinguish between average FAQ item scores in the MCI-P group at visits F-1 and F, specificity dropped to 62.3% and classification accuracy fell to 68.1%.

Since the classification accuracies exhibited by cut-offs derived from global FAQ indices measured at visit F in this longitudinal cohort were consistently lower than those from prior cross-sectional analyses [17], we subsequently examined the performance of cut-offs derived from the magnitude of the changes in global FAQ indices between the F-1 and F assessments. ROC analyses of changes in total FAQ scores in the MCI-S and MCI-P groups between F-1 and F produced an AUC of 0.780 (95% CI: 0.752-0.809, p<0.001] and d’ of 0.99. The optimal cut-point was between 2 and 3, which yielded 70.1% sensitivity, 79.3% specificity, and 75.4% classification accuracy. ROC analyses of changes in average FAQ item scores in the MCI-S and MCI-P groups between F-1 and F produced an AUC of 0.769 (95% CI: 0.749-0.789, p<0.001] and d’ of 0.97. The optimal cut-point was between 0.275 and 0.276, which yielded 68.7% sensitivity, 77.7% specificity, and 73.6% classification accuracy. When these cut-points were used to distinguish changes in these indices within the MCI-P group from F-2 to F-1 and F-1 to F, poorer specificity (change in total FAQ: 61.9%; change in average FAQ item: 60.7%) and classification accuracy (change in total FAQ: 66.6%; change in average FAQ item: 65.1%) were again seen.

Analyses of FAQ indices in amnestic MCI

Interventional clinical trials in MCI have focused primarily on amnestic MCI, due to its higher rates of progression to dementia relative to non-amnestic MCI [24-27]. Since our data also show a greater prevalence of amnestic MCI in the MCI-P group relative to the MCI-S group, we performed further analyses of FAQ indices limited to individuals diagnosed with amnestic MCI at visit F-1. These additional analyses produced results similar to those performed with the overall cohort (data not shown).

DISCUSSION

Analyses of longitudinal IADL data from the NACC UDS revealed a marked decline in functional abilities across the diagnostic transition between MCI and dementia, as both total FAQ and average FAQ item scores approximately doubled in the MCI-P group across the F-1 to F interval. Over this interval, which averaged 14.5 months, increases in global FAQ indices associated with progression from MCI to dementia were three- to six-fold greater than the analogous increases seen with stable MCI. These findings are consistent with prior reports indicating that functional abilities are more impaired and decline more rapidly in progressive versus stable MCI [4,6,28-32]

Nevertheless, despite the magnitude of the longitudinal increases in global FAQ indices seen in the MCI-P group from F-1 to F, their predictive value for distinguishing MCI from dementia was poorer than that reported from cross-sectional data [17], yielding similar sensitivity, but lower specificity when previously defined cut-points were used. These results suggest that expert ADC clinicians may accept higher levels of functional impairment for the criterion of “essentially intact” ADLs for MCI than previously estimated. The optimal diagnostic cut-point between MCI and dementia calculated from the current longitudinal dataset for total FAQ scores (≥ 9) lies in the upper range of previously reported cut-points for distinguishing between normal cognition and dementia, which range from ≥ 5 [33] to ≥ 12 [34], but yielded poorer predictive value than those previous cross-sectional studies. These results reflect the inherent difficulty of identifying a standardized threshold for longitudinal changes in functional abilities across the diagnostic transition between MCI and dementia.

The longitudinal increases in global FAQ indices seen in the transition from MCI to dementia were not driven by impairments in specific IADLs. Greater interval declines were seen in the MCI-P group between visits F-1 and F in most or all of the individual FAQ items relative to both of the stable MCI comparison groups (MCI-S group from F-1 to F and MCI-P group from F-2 to F-1). Furthermore, logistic regression indicated that increases in 7 out of 10 individual FAQ categories were independently associated with progression to dementia. While these results are consistent with prior cross-sectional analyses that indicated significantly greater impairment in all IADL categories in very mild AD relative to MCI [17], there is some overlap between our results and prior work with the Lawton and Brody scale that identified a specific set of IADL deficits that were most closely associated with a diagnosis of dementia [35]. Taken together, these findings suggest that progression from MCI to dementia is associated with declining performance across a broad range of different IADLs rather than targeted declines in specific tasks. Nevertheless, given the variable difficulty and floor/ceiling effects of different IADLs, some IADL categories may be more closely associated with or predictive of diagnostic progression than others [14,17,35].

Our analyses indicated that poorer IADL performance in both the MCI-S and MCI-P groups was seen in participants who were older and had lower MMSE scores. These findings are consistent with prior reports [14,36,37] and support the hypothesis that individuals that are closer to the diagnostic transition from MCI to dementia (i.e. with more advanced underlying neurodegenerative disease) are more likely to have poorer functional abilities [4,6,28-32]. Our data also showed that non-Hispanic White participants had significantly greater IADL impairments than minority participants. This finding conflicts with previous epidemiological studies of elderly individuals, which have identified greater IADL deficits in ethnic minorities than in non-Hispanic Whites [36,38]. However, minority participants may be more likely than non-Hispanic Whites to be diagnosed with MCI [39], particularly non-amnestic MCI [5,40,41], which has been shown in some studies to be less likely to progress to dementia [24-27]. Since ethnic discrepancies are larger for the prevalence of MCI than for the prevalence of dementia [42], a higher proportion of MCI diagnoses in ethnic minorities may reflect nonneurodegenerative etiologies, possibly due to cultural effects on normative data for the neuropsychological assessments, especially in non-memory domains [43-45]. Therefore, the less severe functional impairments reported in ethnic minority MCI participants in the NACC UDS database may reflect a lower likelihood of underlying neurodegenerative disease.

The limited discriminatory power of global FAQ indices for distinguishing between MCI and dementia in this longitudinal cohort can be interpreted in a number of ways. One view is that questionnaires assessing IADL function may have little value for defining the threshold of functional impairment needed for a diagnosis of dementia [46,47], leaving open the possibility that performance-based IADL assessment tools may have greater utility for this distinction [48,49]. However, it is also possible that other IADL questionnaires with greater precision than the FAQ may have greater utility for this purpose. Alternatively, clinician judgment, the current “gold standard” for assessing IADL impairment [2] used across ADCs [17] may be variable enough between expert raters, particularly in longitudinal assessments, to limit its correlation with more formal IADL ratings, thus reducing their diagnostic accuracy. This interpretation becomes particularly problematic when clinical trials of potential therapeutic interventions for MCI are considered. Some studies have used time to progression to dementia as their primary outcome measure and appear to have incorporated subjective clinician judgment of IADL performance into their dementia diagnoses [50]. The potential additional variability associated with using clinician judgment for determining functional impairment may further contribute to the difficulties associated with assessing potential treatments for MCI.

This study analyzed longitudinal FAQ data from a large number of participants diagnosed with MCI by expert clinicians at multiple ADCs across the United States, allowing for IADL assessments and clinical diagnoses across a wide range of geographic and demographic regions, thus increasing the generalizability of our findings. However, there are a number of factors that may limit the interpretation of our results. The NACC UDS is a convenience sample of participants volunteering for research at academic centers, and may differ from community-based epidemiological samples, particularly in participants’ high levels of educational attainment. Diagnoses of MCI and dementia in the NACC UDS are based on clinical criteria [1,21], and inter-ADC variability in the operationalization of both the cognitive and functional aspects of these criteria may have affected our results. Although the NACC UDS diagnoses represent the “gold standard” for the analyses that we have performed, the use of clinical judgment for assessing for significant declines in IADLs necessarily inserts a subjective component to the diagnostic process. A significant proportion of subjects in both the MCI-S and MCI-P groups had incomplete FAQ data from at least one visit. Incomplete FAQ data were more common in the MCI-P group, raising the possibility that these participants may have had fewer premorbid IADL responsibilities or that their informants may have been less knowledgeable about their abilities. Nevertheless, prior work suggests that informants provide more accurate IADL ratings than MCI subjects, who frequently underestimate their IADL deficits [6]. Although similar longitudinal patterns were seen using both global FAQ indices, total FAQ scores provided better classification accuracy than average FAQ item scores, despite the fact that the majority of participants with incomplete data were missing data for only 1 or 2 items. These results confirm our prior report suggesting that the FAQ may have greater diagnostic utility when complete data are available [17]. However, our findings have not accounted for the possible presence of other medical comorbidities beyond cognitive impairment that may have impacted assessments of IADL performance.

Our analyses of longitudinal IADL data in individuals with baseline diagnoses of MCI reveal large increases in FAQ scores across the transition from MCI to dementia, but also suggest significant overlap in the distributions of FAQ scores between these diagnoses. The poorer utility of global FAQ indices for the finer distinctions between MCI and dementia in this longitudinal dataset relative to prior cross-sectional analyses [17] is not wholly unexpected, but reinforces previous concerns regarding the difficulty of operationalizing the criterion of “essentially intact” ADLs in MCI [15,16]. Future clinical trials of interventions aimed at delaying progression from MCI to dementia may require the development of more consistent and reliable determinations of the severity of IADL deficits that separates these diagnoses.

ACKNOWLEDGMENTS

National Institute on Aging (P50 AG16570, K23 AG028727 [to PL], and K08 AG34628 [to ET; jointly sponsored by NIA, AFAR, the John A. Hartford Foundation, the Atlantic Philanthropies, the Starr Foundation and an anonymous donor]), the Alzheimer's Disease Research Centers of California, and the Sidell-Kagan Foundation. The NACC database is funded by NIA (U01 AG016976).

REFERENCES

  • 1.Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194. doi: 10.1111/j.1365-2796.2004.01388.x. [DOI] [PubMed] [Google Scholar]
  • 2.McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263–269. doi: 10.1016/j.jalz.2011.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279. doi: 10.1016/j.jalz.2011.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A. Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry. 2007;22:1217–1222. doi: 10.1002/gps.1816. [DOI] [PubMed] [Google Scholar]
  • 5.Teng E, Becker BW, Woo E, Cummings JL, Lu PH. Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30:189–197. doi: 10.1159/000313540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP. Functional deficits in patients with mild cognitive impairment: Prediction of AD. Neurology. 2002;58:758–764. doi: 10.1212/wnl.58.5.758. [DOI] [PubMed] [Google Scholar]
  • 7.Farias ST, Mungas D, Reed BR, Harvey D, Cahn-Weiner D, Decarli C. MCI is associated with deficits in everyday functioning. Alzheimer Dis Assoc Disord. 2006;20:217–223. doi: 10.1097/01.wad.0000213849.51495.d9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jefferson AL, Byerly LK, Vanderhill S, Lambe S, Wong S, Ozonoff A, Karlawish JH. Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry. 2008;16:375–383. doi: 10.1097/JGP.0b013e318162f197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kim KR, Lee KS, Cheong HK, Eom JS, Oh BH, Hong CH. Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;27:278–285. doi: 10.1159/000204765. [DOI] [PubMed] [Google Scholar]
  • 10.Perneczky R, Pohl C, Sorg C, Hartmann J, Tosic N, Grimmer T, Heitele S, Kurz A. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry. 2006;21:158–162. doi: 10.1002/gps.1444. [DOI] [PubMed] [Google Scholar]
  • 11.Wadley VG, Crowe M, Marsiske M, Cook SE, Unverzagt FW, Rosenberg AL, Rexroth D. Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly study. J Am Geriatr Soc. 2007;55:1192–1198. doi: 10.1111/j.1532-5415.2007.01245.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Reppermund S, Brodaty H, Crawford JD, Kochan NA, Draper B, Slavin MJ, Trollor JN, Sachdev PS. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: The Sydney Memory and Ageing study. Psychol Med. 2013;43:2437–2445. doi: 10.1017/S003329171200308X. [DOI] [PubMed] [Google Scholar]
  • 13.Yeh YC, Lin KN, Chen WT, Lin CY, Chen TB, Wang PN. Functional disability profiles in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2011;31:225–232. doi: 10.1159/000326910. [DOI] [PubMed] [Google Scholar]
  • 14.Brown PJ, Devanand DP, Liu X, Caccappolo E. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry. 2011;68:617–626. doi: 10.1001/archgenpsychiatry.2011.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gold DA. An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment. J Clin Exp Neuropsychol. 2012;34:11–34. doi: 10.1080/13803395.2011.614598. [DOI] [PubMed] [Google Scholar]
  • 16.Han JW, Lee SB, Kim TH, Park JH, Lee JJ, Huh YS, Choi EA, Choe JY, Do YJ, Lee DY, Kim KW. Functional impairment in the diagnosis of mild cognitive impairment. Alzheimer Dis Assoc Disord. 2011;25:225–229. doi: 10.1097/WAD.0b013e318209d517. [DOI] [PubMed] [Google Scholar]
  • 17.Teng E, Becker BW, Woo E, Knopman DS, Cummings JL, Lu PH. Utility of the Functional Activities Questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24:348–353. doi: 10.1097/WAD.0b013e3181e2fc84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sanchez-Benavides G, Manero RM, Quinones-Ubeda S, de Sola S, Quintana M, Pena-Casanova J. Spanish version of the Bayer Activities of Daily Living scale in mild cognitive impairment and mild Alzheimer disease: Discriminant and concurrent validity. Dement Geriatr Cogn Disord. 2009;27:572–578. doi: 10.1159/000228259. [DOI] [PubMed] [Google Scholar]
  • 19.de Rotrou J, Wu YH, Hugonot-Diener L, Thomas-Anterion C, Vidal JS, Plichart M, Rigaud AS, Hanon O. DAD-6: A 6-ltem version of the Disability Assessment for Dementia scale which may differentiate Alzheimer's disease and mild cognitive impairment from controls. Dement Geriatr Cogn Disord. 2012;33:210–218. doi: 10.1159/000338232. [DOI] [PubMed] [Google Scholar]
  • 20.Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA. The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20:210–216. doi: 10.1097/01.wad.0000213865.09806.92. [DOI] [PubMed] [Google Scholar]
  • 21.McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology. 1984;34:939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  • 22.Pfeffer RI, Kurosaki TT, Harrah CH, Jr., Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323–329. doi: 10.1093/geronj/37.3.323. [DOI] [PubMed] [Google Scholar]
  • 23.Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  • 24.Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: Long-term course of four clinical subtypes. Neurology. 2006;67:2176–2185. doi: 10.1212/01.wnl.0000249117.23318.e1. [DOI] [PubMed] [Google Scholar]
  • 25.Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68:288–291. doi: 10.1212/01.wnl.0000252358.03285.9d. [DOI] [PubMed] [Google Scholar]
  • 26.Rasquin SM, Lodder J, Visser PJ, Lousberg R, Verhey FR. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: A 2-year follow-up study. Dement Geriatr Cogn Disord. 2005;19:113–119. doi: 10.1159/000082662. [DOI] [PubMed] [Google Scholar]
  • 27.Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Pantieri G, Mariani E. Conversion of mild cognitive impairment to dementia: Predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord. 2006;21:51–58. doi: 10.1159/000089515. [DOI] [PubMed] [Google Scholar]
  • 28.Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, Tzourio C, Rouaud O, Poncet M, Pasquier F, Auriacombe S, Touchon J, Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008;79:979–984. doi: 10.1136/jnnp.2007.136903. [DOI] [PubMed] [Google Scholar]
  • 29.Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, Inzitari D. CIND and MCI in the Italian elderly: Frequency, vascular risk factors, progression to dementia. Neurology. 2007;68:1909–1916. doi: 10.1212/01.wnl.0000263132.99055.0d. [DOI] [PubMed] [Google Scholar]
  • 30.Peres K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. Restriction in complex activities of daily living in MCI: Impact on outcome. Neurology. 2006;67:461–466. doi: 10.1212/01.wnl.0000228228.70065.f1. [DOI] [PubMed] [Google Scholar]
  • 31.Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G. Cerebral atrophy, apolipoprotein E ε4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment. Alzheimers Dement. 2010;6:404–411. doi: 10.1016/j.jalz.2010.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chang YL, Bondi MW, McEvoy LK, Fennema-Notestine C, Salmon DP, Galasko D, Hagler DJ, Jr., Dale AM. Global Clinical Dementia Rating of 0.5 in MCI masks variability related to level of function. Neurology. 2011;76:652–659. doi: 10.1212/WNL.0b013e31820ce6a5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Castilla-Rilo J, Lopez-Arrieta J, Bermejo-Pareja F, Ruiz M, Sanchez-Sanchez F, Trincado R. Instrumental activities of daily living in the screening of dementia in population studies: A systematic review and meta-analysis. Int J Geriatr Psychiatry. 2007;22:829–836. doi: 10.1002/gps.1747. [DOI] [PubMed] [Google Scholar]
  • 34.Aprahamian I, Martinelli JE, Cecato J, Yassuda MS. Screening for Alzheimer's disease among illiterate elderly: Accuracy analysis for multiple instruments. J Alzheimers Dis. 2011;26:221–229. doi: 10.3233/JAD-2011-110125. [DOI] [PubMed] [Google Scholar]
  • 35.Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc. 1992;40:1129–1134. doi: 10.1111/j.1532-5415.1992.tb01802.x. [DOI] [PubMed] [Google Scholar]
  • 36.Ciol MA, Shumway-Cook A, Hoffman JM, Yorkston KM, Dudgeon BJ, Chan L. Minority disparities in disability between Medicare beneficiaries. J Am Geriatr Soc. 2008;56:444–453. doi: 10.1111/j.1532-5415.2007.01570.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement. 2011;7:300–308. doi: 10.1016/j.jalz.2010.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Coustasse A, Bae S, Arvidson C, Singh KP, Trevino F. Disparities in ADL and IADL disabilities among elders of Hispanic subgroups in the United States: Results from the National Health Interview Survey 2001-2003. Hosp Top. 2009;87:15–23. doi: 10.3200/HTPS.87.1.15-23. [DOI] [PubMed] [Google Scholar]
  • 39.Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: Part 1. Arch Neurol. 2003;60:1385–1389. doi: 10.1001/archneur.60.10.1385. [DOI] [PubMed] [Google Scholar]
  • 40.He J, Farias S, Martinez O, Reed B, Mungas D, Decarli C. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein e4 among mild cognitive impairment subtypes. Arch Neurol. 2009;66:1393–1399. doi: 10.1001/archneurol.2009.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Teng E, Tingus KD, Lu PH, Cummings JL. Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;28:168–178. doi: 10.1159/000235732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Low LF, Harrison F, Kochan NA, Draper B, Slavin MJ, Reppermund S, Sachdev PS, Brodaty H. Can mild cognitive impairment be accurately diagnosed in English speakers from linguistic minorities? Results from the Sydney Memory and Ageing study. Am J Geriatr Psychiatry. 2012;20:866–877. doi: 10.1097/JGP.0b013e31823e31e2. [DOI] [PubMed] [Google Scholar]
  • 43.Boone KB, Victor TL, Wen J, Razani J, Ponton M. The association between neuropsychological scores and ethnicity, language, and acculturation variables in a large patient population. Arch Clin Neuropsychol. 2007;22:355–365. doi: 10.1016/j.acn.2007.01.010. [DOI] [PubMed] [Google Scholar]
  • 44.Manly JJ, Bell-McGinty S, Tang MX, Schupf N, Stern Y, Mayeux R. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol. 2005;62:1739–1746. doi: 10.1001/archneur.62.11.1739. [DOI] [PubMed] [Google Scholar]
  • 45.Manly JJ, Jacobs DM, Touradji P, Small SA, Stern Y. Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc. 2002;8:341–348. doi: 10.1017/s1355617702813157. [DOI] [PubMed] [Google Scholar]
  • 46.Hancock P, Larner AJ. The diagnosis of dementia: Diagnostic accuracy of an instrument measuring activities of daily living in a clinic-based population. Dement Geriatr Cogn Disord. 2007;23:133–139. doi: 10.1159/000097994. [DOI] [PubMed] [Google Scholar]
  • 47.Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007;24:375–379. doi: 10.1159/000109268. [DOI] [PubMed] [Google Scholar]
  • 48.Farias ST, Harrell E, Neumann C, Houtz A. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: Ecological validity of neuropsychological tests. Arch Clin Neuropsychol. 2003;18:655–672. [PubMed] [Google Scholar]
  • 49.Wadley VG, Okonkwo O, Crowe M, Ross-Meadows LA. Mild cognitive impairment and everyday function: Evidence of reduced speed in performing instrumental activities of daily living. Am J Geriatr Psychiatry. 2008;16:416–424. doi: 10.1097/JGP.0b013e31816b7303. [DOI] [PubMed] [Google Scholar]
  • 50.Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–2388. doi: 10.1056/NEJMoa050151. [DOI] [PubMed] [Google Scholar]

RESOURCES